Obesity and Longer Term Risks of Dementia in 65-74 Year Olds.


Journal

Age and ageing
ISSN: 1468-2834
Titre abrégé: Age Ageing
Pays: England
ID NLM: 0375655

Informations de publication

Date de publication:
01 05 2019
Historique:
received: 10 05 2018
revised: 31 10 2018
accepted: 09 01 2019
pubmed: 7 2 2019
medline: 12 5 2020
entrez: 7 2 2019
Statut: ppublish

Résumé

overweight or obesity at ages <65 years associates with increased dementia incidence, but at ≥65 years estimates are paradoxical. Weight loss before dementia diagnosis, plus smoking and diseases causing weight loss may confound associations. to estimate weight loss before dementia diagnosis, plus short and longer-term body mass index associations with incident dementia in 65-74 year olds within primary care populations in England. we studied dementia diagnosis free subjects: 257,523 non-smokers without baseline cancer, heart failure or multi-morbidity (group A) plus 161,927 with these confounders (group B), followed ≤14.9 years. Competing hazard models accounted for mortality. in group A, 9,774 were diagnosed with dementia and in those with repeat weight measures, 54% lost ≥2.5 kg during 10 years pre-diagnosis. During <10 years obesity (≥30.0 kg/m2) or overweight (25.0 to <30.0) were inversely associated with incident dementia (versus 22.5 to <25.0). However, from 10 to 14.9 years, obesity was associated with increased dementia incidence (hazard ratio [HR] 1.17; 95% CI: 1.03-1.32). Overweight protective associations disappeared in longer-term analyses (HR, 1.01; 95% CI: 0.90-1.13). In group B, (n = 6,070 with incident dementia), obesity was associated with lower dementia risks in the short and longer-term. in 65-74 year olds (free of smoking, cancer, heart failure or multi-morbidity at baseline) obesity associates with higher longer-term incidence of dementia. Paradoxical associations were present short-term and in those with likely confounders. Reports of protective effects of obesity or overweight on dementia risk in older groups may reflect biases, especially weight loss before dementia diagnosis.

Sections du résumé

BACKGROUND
overweight or obesity at ages <65 years associates with increased dementia incidence, but at ≥65 years estimates are paradoxical. Weight loss before dementia diagnosis, plus smoking and diseases causing weight loss may confound associations.
OBJECTIVE
to estimate weight loss before dementia diagnosis, plus short and longer-term body mass index associations with incident dementia in 65-74 year olds within primary care populations in England.
METHODS
we studied dementia diagnosis free subjects: 257,523 non-smokers without baseline cancer, heart failure or multi-morbidity (group A) plus 161,927 with these confounders (group B), followed ≤14.9 years. Competing hazard models accounted for mortality.
RESULTS
in group A, 9,774 were diagnosed with dementia and in those with repeat weight measures, 54% lost ≥2.5 kg during 10 years pre-diagnosis. During <10 years obesity (≥30.0 kg/m2) or overweight (25.0 to <30.0) were inversely associated with incident dementia (versus 22.5 to <25.0). However, from 10 to 14.9 years, obesity was associated with increased dementia incidence (hazard ratio [HR] 1.17; 95% CI: 1.03-1.32). Overweight protective associations disappeared in longer-term analyses (HR, 1.01; 95% CI: 0.90-1.13). In group B, (n = 6,070 with incident dementia), obesity was associated with lower dementia risks in the short and longer-term.
CONCLUSIONS
in 65-74 year olds (free of smoking, cancer, heart failure or multi-morbidity at baseline) obesity associates with higher longer-term incidence of dementia. Paradoxical associations were present short-term and in those with likely confounders. Reports of protective effects of obesity or overweight on dementia risk in older groups may reflect biases, especially weight loss before dementia diagnosis.

Identifiants

pubmed: 30726871
pii: 5307819
doi: 10.1093/ageing/afz002
pmc: PMC6512743
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

367-373

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the British Geriatrics Society.

Références

Am J Clin Nutr. 2008 Apr;87(4):801-9
pubmed: 18400700
Mol Psychiatry. 2016 Jul;21(7):910-5
pubmed: 26324099
PLoS One. 2011 Mar 25;6(3):e17902
pubmed: 21464984
Arch Neurol. 2005 Oct;62(10):1556-60
pubmed: 16216938
Lancet Diabetes Endocrinol. 2015 Jun;3(6):431-436
pubmed: 25866264
J Am Geriatr Soc. 2017 Mar;65(3):511-519
pubmed: 27991654
J Clin Epidemiol. 2005 Jan;58(1):13-9
pubmed: 15649666
Lancet. 2016 Aug 20;388(10046):776-86
pubmed: 27423262
Alzheimer Dis Assoc Disord. 2006 Apr-Jun;20(2):93-100
pubmed: 16772744
Arch Neurol. 2009 Mar;66(3):336-42
pubmed: 19273752
Arch Neurol. 2005 Jan;62(1):55-60
pubmed: 15642850
BMJ Open. 2016 Jan 13;6(1):e008840
pubmed: 26762161
J Am Geriatr Soc. 2008 Jan;56(1):111-6
pubmed: 18028342
Int J Epidemiol. 2015 Jun;44(3):827-36
pubmed: 26050254
J Alzheimers Dis. 2014;38(1):201-9
pubmed: 23948937
Neurology. 2007 Dec 11;69(24):2197-204
pubmed: 17568013
Arch Intern Med. 2003 Jul 14;163(13):1524-8
pubmed: 12860573
Lancet. 1998 Jun 20;351(9119):1840-3
pubmed: 9652667
PLoS Med. 2009 Nov;6(11):e1000180
pubmed: 19901977
Alzheimers Dement (Amst). 2017 Jun 20;8:165-178
pubmed: 28761927
Alzheimers Dement. 2018 May;14(5):601-609
pubmed: 29169013
Neurology. 2007 Aug 21;69(8):739-46
pubmed: 17709705
J Am Geriatr Soc. 2010 Apr;58(4):681-7
pubmed: 20345864
J Gerontol A Biol Sci Med Sci. 2017 Feb;72(2):203-209
pubmed: 27492450
BMJ. 2005 Jun 11;330(7504):1360
pubmed: 15863436

Auteurs

Kirsty Bowman (K)

Epidemiology and Public Health, Institute of Biomedical and Clinical Science, University of Exeter Medical School, Barrack Road, Exeter, UK.

Madhav Thambisetty (M)

Unit of Clinical and Translational Neuroscience, Laboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, USA.

George A Kuchel (GA)

UConn Center on Aging, University of Connecticut Health Center, Farmington, USA.

Luigi Ferrucci (L)

Longitudinal Studies Section, National Institutes of Health, Harbor Hospital, Baltimore, MD, USA.

David Melzer (D)

Epidemiology and Public Health, Institute of Biomedical and Clinical Science, University of Exeter Medical School, Barrack Road, Exeter, UK.
UConn Center on Aging, University of Connecticut Health Center, Farmington, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH